-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Mass Spectrometry vs. MRD

Program: Scientific Workshops @ ASH
Session: Adaption of Next Generation Sequencing, Next Generation Flow Cytometry, and CyTOF: Diverse Ways of Detection
Thursday, December 3, 2020, 8:32 AM-9:12 AM

David M Foureau, PhD

Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC

Disclosures: Foureau: Celgene: Research Funding; TeneoBio: Research Funding.